within Pharmacolibrary.Drugs.ATC.D;

model D04AA13
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.7,
    Cl             = 0.002,
    adminDuration  = 600,
    adminMass      = 4 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.003,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0013333333333333333,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>D04AA13</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Dimetindene is a first-generation selective histamine H1 antagonist (antihistamine) with anticholinergic and antipruritic effects. It is mainly used for the symptomatic relief of allergic conditions such as urticaria, allergic rhinitis, and pruritus. Dimetindene is currently available in some countries as both oral and topical formulations, but is not universally approved in all regions.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for oral administration in adults; no direct clinical PK data found in scientific literature.</p><h4>References</h4><ol><li><p>Arnera, V, et al., &amp; Balant, LP (1990). Pharmacokinetics of dimetindene after intravenous and oral administration to healthy volunteers. <i>Arzneimittel-Forschung</i> 40(12) 1346–1348. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2095130/\">https://pubmed.ncbi.nlm.nih.gov/2095130</a></p></li><li><p>Prien, D, et al., &amp; Blaschke, G (1997). Enantioselective biotransformation of the chiral antihistaminic drug dimethindene in humans and rats. <i>Arzneimittel-Forschung</i> 47(5) 653–658. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/9205781/\">https://pubmed.ncbi.nlm.nih.gov/9205781</a></p></li><li><p>Rehn, D, et al., &amp; Hennings, G (1990). Effect-kinetic characterization of dimethindene maleate following oral administration (Fenistil, Tropfen). <i>Fundamental &amp; clinical pharmacology</i> 4(6) 673–683. DOI:<a href=\"https://doi.org/10.1111/j.1472-8206.1990.tb00047.x\">10.1111/j.1472-8206.1990.tb00047.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2096106/\">https://pubmed.ncbi.nlm.nih.gov/2096106</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end D04AA13;
